Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Episurf Medical provides update on process for UK NICE guidelines

Episurf Medical (NASDAQ: EPIS B) today provides an update on the work related to the UK National Institute for Health and Care Excellence’s (NICE) guidelines. NICE guidelines are evidence-based recommendations for health and care in the UK, to help healthcare professionals in their work. The guidelines also support payors and authorities on their decisions to reimburse various procedures and devices. Episurf Medical has participated in several NICE hearings for its Episealer® knee implant family, and the company has been informed about the timetable, which is likely to result in guidelines

Vicore IPF interim data selected as an oral “late-breaker” at the ERS congress

· The AIR trial is a single arm, multicenter phase 2 study in patients with idiopathic pulmonary fibrosis (IPF) · Interim data have shown stabilization of the disease and an increase in lung capacity at 24 and 36 weeks · Oral presentation by Professor Toby Maher on September 4 at 15:00 CET   Gothenburg, August 17, 2022 - Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), today announces that the previously published interim data from AIR, a phase 2 trial in IPF), will be

Notice of Annual General Meeting in Pomegranate Investment AB

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONThe shareholders in Pomegranate Investment AB (publ) with Reg. No. 556967-7247 and registered office in Stockholm are hereby convened to the annual general meeting to be held on 14 September 2022 at 3 p.m. at the offices of Advokatfirman Vinge, Smålandsgatan 20, SE-111 46 Stockholm.   Preconditions for participation Shareholders who wish to participate in the general meeting must be included in the shareholders’ register maintained by Euroclear Sweden AB as of 6 September 2022. Nominee registered shares To

TikoMed Announces Appointment of Two Independent Directors

Viken – 17th August, 2022 – Today, Swedish biopharmaceutical company TikoMed AB announced the appointment of two new members to its Board of Directors, Tara Heitner and Pete Zorn. “We are excited to welcome Tara and Pete to our Board,” said Adam Bruce, Founder and Chairman of the Board of TikoMed. “Tara and Pete are perfect fits for our next steps with their strong track records of transactional experience. They bring years of organizational and business development expertise and leadership that will serve the company well as we aim to grow our business focused on the ILB® drug platform

Inify’s first ultramodern laboratory on track

STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. “We signed a five-year leasing contract for our office and laboratory facilities at Campus Solna. These will be Inify’s headquarters, housing our first laboratory as well as our Center of Excellence,” says CEO Fredrik Palm at Inify. The company expects to move into the new facility

Implema partners with Litorina to accelerate growth - Lars Wollung new chairman of the board

Implema, Sweden’s leading implementation specialist for SAP and Microsoft Dynamics enters a new phase in its growth journey as it partners with private equity company Litorina and announces Lars Wollung as chairman of the board. The partnership will enable Implema to accelerate growth by expanding its service offering, strengthening its position as a long-term digital transformation partner. Litorina is a Swedish private equity firm with extensive experience partnering with innovative companies in the Nordics. With this move, Litorina takes a majority stake in Implema, while Implema’s

Remedy Entertainment Oyj: Managers' Transactions – Kaisa Salakka

Remedy Entertainment Oyj – Managers' Transactions 17 August 2022 9.00 a.m. (EEST) ____________________________________________ Person subject to the notification requirementName: Kaisa SalakkaPosition: Member of the BoardIssuer: Remedy Entertainment OyjLEI: 7437003VZ3JPF7DBTG92Notification type: INITIAL NOTIFICATIONReference number: 18520/4/6 ____________________________________________ Transaction date: 2022-08-16Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000251897Nature of the transaction: ACQUISITION Transaction details (1):

SmartCraft ASA (SMCRT) - Invitation to presentation of the second quarter 2022 results and deep dive presentation

SmartCraft ASA | Non-regulatory press releases 17 August 2022 - SmartCraft ASA has the pleasure of inviting investors, analysts, media and other stakeholders to its presentation of the second quarter 2022 financial report followed by a deep-dive presentation of the company’s growth strategy, products and technology. The event will be fully virtual, with opportunity for viewers to ask written questions during and after the event. Time: 25 August 2022 at 9:30-11:00 CET Webcast address: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20220825_2 Program (subject to

Idogen to convene major owners for election to Board

Idogen AB (publ) announced today that an Extraordinary General Shareholder Meeting will be convened to propose the election of two new members to the Board of Directors: Joakim Söderström and Niklas Wallett, representing a consortium that owns approximately 17% of the votes. The election of Joakim Söderström as new Chairman of the Board has also been proposed. Current Board members Leif G. Salford and Lennart Svensson have yielded their positions and their removal from office has been proposed in conjunction with the election of the two new Board members. Current Chairman of the Board

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

Lundbeck’s sales increased by +7% (+3% in local currencies) to DKK 8,847 million in the first half of 2022

HIGHLIGHTS Strategic brands are significant growth drivers of strong operational performance growing +27% (+19% in local currencies) in the first half of 2022 representing 63% of overall revenue · Brintellix[®]/Trintellix[®]: +24% reported to DKK 2,051 million (+17% in local currencies) · Rexulti[®]/Rxulti[®]: +29% reported to DKK 1,771 million (+17% in local currencies) · Abilify Maintena[®]: +16% reported to DKK 1,393 million (+11% in local currencies) · Vyepti[®]: +120% reported to DKK 390 million (+100% in local currencies) All markets contribute to revenue momentum

Panoro Energy – Invitation to Half Year 2022 Results Presentation

Oslo, 17 August 2022 - The Half Year 2022 Report to be announced on Wednesday 24 August will be available on our website http://www.panoroenergy.com at 07:30 a.m. CEST. The company will hold a live webinar presentation at 09:00 a.m. CEST on Wednesday 24 August 2022, during which management will discuss the results and operations, followed by a Q&A session. The webinar presentation can be accessed through registering at the link below and the online event will be equipped with features to ask live questions. Joining instructions for participating online or through using local dial-in

QUARTERLY REPORT APRIL TO JUNE 2022

CONTINUED HIGH GROWTH REVENUE TRAJECTORY – QUARTERLY SAAS ARR GROWTH OF 55%APRIL TO JUNE 2022 · Net sales amounted to 10.2 MSEK (8.2), + 24% · Recurring revenues amounted to 9.1 MSEK (6.3), + 44% · SaaS ARR amounted to 20.0 MSEK, +55% compared with March 2022 · SaaS API Call Volumes 9.3 million, + 70% compared with March 2022 · Gross margin 67% (67) · EBITDA adjusted amounted to -22.4 MSEK (-17.2) · Earnings per share (*) amounted to -2.4 SEK (-2.3) JANUARY TO JUNE 2022 · Net sales amounted to 20.3 MSEK (18.1), + 13% · Recurring revenues amounted to 17.8

Interim report 1 January – 30 June 2022

Evaluating strategic optionsSECOND QUARTER 2022 · Revenue increased by 6% to SEK 1,691m (1,590) · Operating profit increased by 2% to SEK 147m (144) · Operating margin decreased to 8.7% (9.0) · The result for the period decreased by 63% to SEK 32m (86) · Basic earnings per share amounted to SEK 2.20 (5.94) · Cash flows from operating activities amounted to SEK 39m (120) JANUARY - JUNE 2022 · Revenue increased by 20% to SEK 3,436m (2,856) · Operating profit increased by 14% to SEK 255m (224) · Operating margin decreased to 7.4% (7.8) · The result for the

Sitowise’s Half-year Report January – June 2022: Double-digit growth in net sales continued

Sitowise Group Plc, Half-year Report 1 January – 30 June 2022, 17 August 2022 at 8:30 am Q2: Double-digit growth in net sales continuedApril–June in brief (Q2) · Net sales increased by 11% to EUR 51.7 (46.5) million. · Organic net sales grew by 4% (-5%). · Adjusted EBITA was EUR 4.9 (5.9) million, or 9.5% (12.7%) of net sales. · The order book increased by 21% to EUR 169 (140) million. · Leverage (net debt / adjusted EBITDA) rose as a result of acquisitions and was 2.7x (1.5x). · Sitowise carried out three acquisitions. In June, the Group was joined by two Finnish

Karo Intressenter AB publishes the offer document for the public cash offer to the shareholders of Karo Pharma Aktiebolag

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand or South Africa, or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law or otherwise contemplated in connection

INTERIM REPORT FOR THE SECOND QUARTER 2022 NEW WAVE GROUP AB

PERIOD 1 APRIL – 30 JUNE 2022 · Net sales amounted to SEK 2,019.2 million, which was 36% (30% in local currencies) higher than last year (SEK 1,486.8 million). · Operating result amounted to SEK 351.0 (241.3) million. · Result for the period amounted to SEK 265.0 (187.7) million. · Earnings per share amounted to SEK 3.99 (2.84). · Cash flow from operating activities amounted to SEK 68.1 (185.3) million.   PERIOD 1 JANUARY – 30 JUNE 2022 · Net sales amounted to SEK 3,794.1 million, which was 38% (32% in local currencies) higher than last year (SEK 2,748.4 million).

SSG: Strong foundation for further growth

(Oslo, August 17, 2022) Self Storage Group ASA (Self Storage Group, OSE:SSG) continues its positive development in the second quarter with all time high revenue and EBITDA. A strong balance sheet combined with a solid pipeline provides flexibility and an attractive foundation for further growth in the Nordics.Revenues in Q2 2022 was NOK 97.9 million, up 14% from NOK 85.9 million in the corresponding quarter in 2021, and adjusted EBITDA of NOK 59.6 million, was a 9% increase from 54.5 million in the corresponding quarter in 2021. In the first half year 2022 SSG had all time high revenues of

Aker ASA: Half-Year and Second Quarter Results 2022 – Net Asset Value increase of NOK 2.2 billion in the first half of the year

The Net Asset Value (“NAV”) of Aker ASA and holding companies (“Aker”) increased with NOK 2.2 billion, or 3.1 per cent, to NOK 72.0 billion in the first half of the year, net of dividends paid in the period of NOK 1.1 billion. For the second quarter of 2022, the NAV decreased with NOK 2.8 billion, or 3.7 per cent, compared to the first quarter of 2022, including NOK 1.1 billion in dividends paid.The per-share NAV amounted to NOK 968 as per 30 June 2022, compared to NOK 939 as per 31 December 2021. The Aker share decreased 6.6 per cent, dividend adjusted to NOK 756 in the first half of the

ICA Gruppen’s interim report for the second quarter 2022

Stable performance – challenging world· ICA Gruppen’s Q2 sales increased by 6.7% to SEK 34,578 million (32,401). · Operating profit for the second quarter of 2022 (SEK 1,531 million) rose 5.9% compared with the second quarter of 2021 (SEK 1,446 million). · Very high inflationary pressure and continued macroeconomic uncertainty affected the quarter as a whole. · Strong operating profit driven mainly by continued improvement for Apotek Hjärtat as well as for ICA Bank. · ICA Sweden showed stable performance, even though ICA’s store sales were weaker than market growth and the

MPC Energy Solutions publishes Q2 2022 report

Amsterdam/Oslo – 17 August 2022 – MPC Energy Solutions N.V. (“MPCES” or “Company”), Amsterdam, published its Q2 2022 report this morning. The Company generated 14.7 GWh of energy during the first half of 2022, and recorded revenues of USD 1.5 million. MPCES reported an operating loss (EBIT) for the first six months of the year of USD 1.6 million (1H 2021: also negative, USD 1.7 million), and a net loss of USD 1.8 million (unchanged from 1H 2021), reflecting that the Company is still in a build-up phase. Given the anticipated delays and a postponement of the commercial operation date

Multiconsult - Solid second quarter and half year result

Multiconsult ASA (OSE: MULTI)Multiconsult’s second quarter EBITA came in at NOK 74.7 million, which gives an EBITA for the first half of 2022 at NOK 243.9 million. The operating EBITA margin in the quarter was 7.1 per cent, and 11.2 per cent in the first half of the year. High activity and solid operational performance, resulted in a growth in net operating revenues of 6.2 per cent to NOK 1 048.5 million in the quarter, while the organic revenue growth was 3.4 per cent. Higher operating expenses in the quarter is driven by an increase in employees from prior acquisitions and increased other

Aker ASA: Assigned Investment Grade Rating

Scope Ratings has assigned an investment grade rating of BBB-/Stable to Aker ASA. Scope has further assigned a first-time rating of BBB- to Aker's senior unsecured debt and an S-2 short-term rating.In the rating report Scope notes that the rating is driven by Aker's low leverage and its controlled cost coverage, balancing cash inflow and outflows, in addition to that the liquidity of Aker's assets further benefits the rating. We see this rating as a recognition of Aker's resilient financial performance and as a means of strengthening our position in the credit markets going forward.

Autumn novelties Fazer Dumle Granola and Fazerina biscuit flour mix will charm everyone

The versatile novelties of Fazer Mills will brighten up the breakfast table, add twist to baking routines and offer more alternatives for those who follow a gluten-free diet. Fazer’s granola range will be complemented with the beloved Dumle and gingerbread flavours. Home bakers can now delight their family and friends with delicious biscuits and moist bread rolls by using the Fazer Leipurit flour mixes, while the Fazer Gluten-free product range will gain several new flake mixtures. The newcomer of marmalade shelf, Fazer Pihlaja, gives new flavour to pastries, and the sweetly spicy Fazer Alku

There are no items matching the current filter
There are no more items matching the current filter
Back to top